389 related articles for article (PubMed ID: 25132177)
1. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.
Huo Y; Nam KH; Ding F; Lee H; Wu L; Xiao Y; Farchione MD; Zhou S; Rajashankar K; Kurinov I; Zhang R; Ke A
Nat Struct Mol Biol; 2014 Sep; 21(9):771-7. PubMed ID: 25132177
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
3. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
[TBL] [Abstract][Full Text] [Related]
4. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
[TBL] [Abstract][Full Text] [Related]
5. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system.
Sinkunas T; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
EMBO J; 2011 Apr; 30(7):1335-42. PubMed ID: 21343909
[TBL] [Abstract][Full Text] [Related]
6. Dynamic mechanisms of CRISPR interference by Escherichia coli CRISPR-Cas3.
Yoshimi K; Takeshita K; Kodera N; Shibumura S; Yamauchi Y; Omatsu M; Umeda K; Kunihiro Y; Yamamoto M; Mashimo T
Nat Commun; 2022 Aug; 13(1):4917. PubMed ID: 36042215
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for promiscuous PAM recognition in type I-E Cascade from E. coli.
Hayes RP; Xiao Y; Ding F; van Erp PB; Rajashankar K; Bailey S; Wiedenheft B; Ke A
Nature; 2016 Feb; 530(7591):499-503. PubMed ID: 26863189
[TBL] [Abstract][Full Text] [Related]
8. Cas3 nuclease-helicase activity assays.
Sinkunas T; Gasiunas G; Siksnys V
Methods Mol Biol; 2015; 1311():277-91. PubMed ID: 25981480
[TBL] [Abstract][Full Text] [Related]
9. Cas3/I-C mediated target DNA recognition and cleavage during CRISPR interference are independent of the composition and architecture of Cascade surveillance complex.
Nimkar S; Anand B
Nucleic Acids Res; 2020 Mar; 48(5):2486-2501. PubMed ID: 31980818
[TBL] [Abstract][Full Text] [Related]
10. Repetitive DNA Reeling by the Cascade-Cas3 Complex in Nucleotide Unwinding Steps.
Loeff L; Brouns SJJ; Joo C
Mol Cell; 2018 May; 70(3):385-394.e3. PubMed ID: 29706536
[TBL] [Abstract][Full Text] [Related]
11. Conformational Dynamics of DNA Binding and Cas3 Recruitment by the CRISPR RNA-Guided Cascade Complex.
van Erp PBG; Patterson A; Kant R; Berry L; Golden SM; Forsman BL; Carter J; Jackson RN; Bothner B; Wiedenheft B
ACS Chem Biol; 2018 Feb; 13(2):481-490. PubMed ID: 29035497
[TBL] [Abstract][Full Text] [Related]
12. Structure Basis for Directional R-loop Formation and Substrate Handover Mechanisms in Type I CRISPR-Cas System.
Xiao Y; Luo M; Hayes RP; Kim J; Ng S; Ding F; Liao M; Ke A
Cell; 2017 Jun; 170(1):48-60.e11. PubMed ID: 28666122
[TBL] [Abstract][Full Text] [Related]
13. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
[TBL] [Abstract][Full Text] [Related]
14. Assembly and Translocation of a CRISPR-Cas Primed Acquisition Complex.
Dillard KE; Brown MW; Johnson NV; Xiao Y; Dolan A; Hernandez E; Dahlhauser SD; Kim Y; Myler LR; Anslyn EV; Ke A; Finkelstein IJ
Cell; 2018 Nov; 175(4):934-946.e15. PubMed ID: 30343903
[TBL] [Abstract][Full Text] [Related]
15. Structure basis for RNA-guided DNA degradation by Cascade and Cas3.
Xiao Y; Luo M; Dolan AE; Liao M; Ke A
Science; 2018 Jul; 361(6397):. PubMed ID: 29880725
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of Thermobifida fusca Cse1 reveals target DNA binding site.
Tay M; Liu S; Yuan YA
Protein Sci; 2015 Feb; 24(2):236-45. PubMed ID: 25420472
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution and biochemical characterization of ribonucleoprotein complexes in Type I-E CRISPR-Cas systems.
Xiao Y; Ke A
Methods Enzymol; 2019; 616():27-41. PubMed ID: 30691647
[TBL] [Abstract][Full Text] [Related]
18. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.
Beloglazova N; Petit P; Flick R; Brown G; Savchenko A; Yakunin AF
EMBO J; 2011 Oct; 30(22):4616-27. PubMed ID: 22009198
[TBL] [Abstract][Full Text] [Related]
19. Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System.
Redding S; Sternberg SH; Marshall M; Gibb B; Bhat P; Guegler CK; Wiedenheft B; Doudna JA; Greene EC
Cell; 2015 Nov; 163(4):854-65. PubMed ID: 26522594
[TBL] [Abstract][Full Text] [Related]
20. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3.
Westra ER; van Erp PB; Künne T; Wong SP; Staals RH; Seegers CL; Bollen S; Jore MM; Semenova E; Severinov K; de Vos WM; Dame RT; de Vries R; Brouns SJ; van der Oost J
Mol Cell; 2012 Jun; 46(5):595-605. PubMed ID: 22521689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
